<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="HE1709F8225664F09A7BA64D51F565369" key="H" public-private="public"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>115 HR 4964 IH: Children’s Product Warning Label Act of 2018</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2018-02-07</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">115th CONGRESS</congress><session display="yes">2d Session</session><legis-num display="yes">H. R. 4964</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20180207">February 7, 2018</action-date><action-desc><sponsor name-id="D000624">Mrs. Dingell</sponsor> introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Federal Food, Drug, and Cosmetic Act to require that children’s cosmetics containing
			 talc include an appropriate warning unless the cosmetics are demonstrated
			 to be asbestos-free, and for other purposes.</official-title></form>
	<legis-body id="H00E3D6E45B6F407183179FEA692123E9" style="OLC">
 <section id="H43E39EBF08EF43559CA28CB1E89683DD" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Children’s Product Warning Label Act of 2018</short-title></quote>.</text> </section><section id="H020141A2B41A4D289910921DAE3D55D9"><enum>2.</enum><header>Labeling of talc in children’s cosmetics</header> <subsection id="HA3B4D7930AFD48AEB23C5D44471BC01E"><enum>(a)</enum><header>Misbranding</header><text display-inline="yes-display-inline">Section 602 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/362">21 U.S.C. 362</external-xref>) is amended by adding at the end the following:</text>
				<quoted-block display-inline="no-display-inline" id="H8A0FDC8820FC452C8EB9EB5C84E8BF8D" style="OLC">
 <subsection id="H5ECD901F6B1946A59BCAB05B5FB1AFAF"><enum>(g)</enum><text display-inline="yes-display-inline">If it is marketed for use in children (meaning individuals under the age of 18) and contains talc (as defined in section 604) unless—</text>
 <paragraph id="H0536CD3BBCB04F38928915C6BCAEA010"><enum>(1)</enum><text>its label includes the following statement printed in conspicuous text: <quote>WARNING: Talc has not been evaluated for asbestos contamination. Asbestos at any level is known to the FDA to cause cancer, including lung cancer and mesothelioma and may be present in this product. This product is not suitable for use by children.</quote>; or</text>
 </paragraph><paragraph id="HAC4DF6407CBD48AC913489B63A7609EC"><enum>(2)</enum><text>a waiver is in effect with respect to the cosmetic pursuant to section 604.</text></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block> </subsection><subsection id="H510031A0E40B4952A01A7BD8AF105327"><enum>(b)</enum><header>Premarket safety verification of talc content</header><text>Chapter VI of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/361">21 U.S.C. 361</external-xref> et seq.) is amended by adding at the end the following:</text>
				<quoted-block display-inline="no-display-inline" id="H1D0AED2B5EA44029BE6E2F664E7F0B78" style="OLC">
					<section id="HDA582A7A059743B9A241A678F1AD4C02"><enum>604.</enum><header>Premarket safety verification of talc content</header>
 <subsection id="H6F92CC10523948088544A5551D01A9FD"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">The Secretary shall waive the applicability of section 602(g)(1) with respect to a cosmetic containing talc if the manufacturer of the cosmetic—</text>
 <paragraph id="HB0C34D9D005743C380C31D85F5681DA8"><enum>(1)</enum><text>attests in writing to the Secretary that the source of the talc is an asbestos-free mine; and</text> </paragraph><paragraph id="H6E14649BAB374E66915C354E8B3EDF1B"><enum>(2)</enum><text>demonstrates to the Secretary that the talc is asbestos-free using the transmission electron microscopy method.</text>
 </paragraph></subsection><subsection id="HF0B05BDF639045C1B7D574F3D524D31C"><enum>(b)</enum><header>Definitions</header><text display-inline="yes-display-inline">In this section:</text> <paragraph id="H6C179CB269BA4D6D9B8FD4E975F543FD"><enum>(1)</enum><text>The term <term>asbestos</term> means the asbestiform varieties of chrysotile (serpentine), crocidolite (rie­beck­ite), amosite (cummingtonitegrunerite), an­tho­phyl­lite, tremolite, and actinolite.</text>
 </paragraph><paragraph id="H5C9A419D0F4F4BE4AF711133F5F24D67"><enum>(2)</enum><text>The term <term>asbestos-free</term> means containing no traceable asbestos fibers.</text> </paragraph><paragraph id="H5D4823C285B8489380A779187F5CAC66"><enum>(3)</enum><text>The term <term>talc</term>—</text>
 <subparagraph id="H9EE2391AD56F4DD1A90A877DFBEA518C"><enum>(A)</enum><text>means a basic silicate of magnesium; and</text> </subparagraph><subparagraph id="H8D5E85706F784639B781C029317EC6C8"><enum>(B)</enum><text>includes talcum powder, hydrous magnesium silicate, non-fibrous talc, non-asbestiform talc, steatite talc, and fibrous non-tremolite talc.</text>
 </subparagraph></paragraph><paragraph id="H795A3DAE58E44F249E125D98B9EBEECC"><enum>(4)</enum><text>The term <term>transmission electron microscopy</term> refers to the asbestos analysis method used by laboratories that—</text> <subparagraph id="H26D8643231484BC3B4A86A85565CBB46"><enum>(A)</enum><text>are accredited by the National Bureau of Standards; and</text>
 </subparagraph><subparagraph id="HFFD76D800A2C4402B0077D3EDED2D5AC"><enum>(B)</enum><text>use the protocol described in appendix A to subpart E of part 763 of title 40, Code of Federal Regulations (or any successor regulations).</text></subparagraph></paragraph></subsection></section><after-quoted-block>.</after-quoted-block></quoted-block>
 </subsection><subsection id="H9F79457EA4DC42BCAB31180D760B7695"><enum>(c)</enum><header>Applicability</header><text display-inline="yes-display-inline">Sections 602(g) and 604 of the Federal Food, Drug, and Cosmetic Act, as added by subsections (a) and (b), apply beginning on the date that is 180 days after the date of enactment of this Act.</text>
 </subsection><subsection id="H59AEF891E6F9436C814BF0E77885D28F"><enum>(d)</enum><header>Regulations</header><text display-inline="yes-display-inline">Not later than 180 days after the date of enactment of this Act, the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, shall promulgate final regulations to implement such sections 602(g) and 604.</text>
			</subsection></section></legis-body></bill>


